MarketScreener Strategies StemRIM

Stocks

Market Closed - Japan Exchange 02:30:00 2026-09-04 EDT			5-day change	1st Jan Change
312.00 ^JPY	-0.64%		-11.11%	+18.63%

07-22	Stemrim Announces Patent Registration in Mexico for Redasemtide as Therapeutic Agent for Cartilage Disorders	CI
07-08	StemRIM Inc. Announces Patent Registration For Stem Cell Gene Therapy Technology SR-GT1 Aimed At Curative Treatment Of Dystrophic Epidermolysis Bullosa In South Korea	CI